Each filer's latest filing for 01671P100 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Tang Capital Management LLC
13D/A
|
100.0% |
5/19/2025
Event 5/15/2025
|
||
| Tang Capital Management, LLC | 100.0% | |||
| Kevin Tang | 100.0% | |||
| Tang Capital Partners, LP | 100.0% | |||
| Tang Capital Partners International, LP | 0% | |||
| Tang Capital Partners III, Inc | 0% | |||
| Tang Capital Partners IV, Inc | 0% | |||
| Concentra Biosciences, LLC | 100.0% | |||
| Concentra Merger Sub III, Inc | 0% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (5) | ||||
|
FMR LLC
13G/A
|
0.3% |
5/12/2025
Event 3/31/2025
|
||
| FMR LLC | 0.3% | |||
| Abigail P. Johnson | 0.3% | |||
|
Biotechnology Value Fund L P
13G/A
|
0% |
5/19/2025
Event 5/15/2025
|
||
| Biotechnology Value Fund L P | 0% | |||
| BVF I GP LLC | 0% | |||
| Biotechnology Value Fund II LP | 0% | |||
| BVF II GP LLC | 0% | |||
| Biotechnology Value Trading Fund OS LP | 0% | |||
| BVF Partners OS Ltd. | 0% | |||
| BVF GP Holdings LLC | 0% | |||
| BVF Partners L P/IL | 0% | |||
| BVF Inc/IL | 0% | |||
| Lampert Mark N | 0% | |||
|
Beryl Capital Management LLC
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| Beryl Capital Management LLC | 0% | |||
| Beryl Capital Management LP | 0% | |||
| Beryl Capital Partners II LP | 0% | |||
| David A. Witkin | 0% | |||
|
Deep Track Capital, LP
13G/A
|
0% |
8/14/2025
Event 6/30/2025
|
||
| Deep Track Capital, LP | 0% | |||
| Deep Track Biotechnology Master Fund, Ltd. | 0% | |||
| David Kroin | 0% | |||
|
New Enterprise Associates 16, L.P.
13D/A
|
0% |
5/16/2025
Event 5/15/2025
|
||
| New Enterprise Associates 16, L.P. | 0% | |||
| NEA Partners 16, L.P. | 0% | |||
| Nea 16 GP, LLC | 0% | |||
| NEA 18 Venture Growth Equity, L.P. | 0% | |||
| NEA Partners 18 VGE, L.P. | 0% | |||
| Nea 18 Vge GP, LLC | 0% | |||
| Ali Behbahani | 0% | |||
| Carmen Chang | 0% | |||
| Anthony A. Florence, Jr. | 0% | |||
| Mohamad H. Makhzoumi | 0% | |||
| Scott D. Sandell | 0% | |||
| Peter W. Sonsini | 0% | |||
| Paul Walker | 0% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2025 Q1 | 66 | 61.9 M | $15.4M |
| 2024 Q4 | 79 | 74.3 M | $90.0M |
| 2024 Q3 | 79 | 70.3 M | $45.9M |
| 2024 Q2 | 102 | 75.6 M | $75.6M |
| 2024 Q1 | 102 | 79.9 M | $101M |
| 2023 Q4 | 110 | 75.5 M | $206M |
| 2023 Q3 | 120 | 72.4 M | $164M |
| 2023 Q2 | 132 | 70.1 M | $306M |
| 2023 Q1 | 132 | 68.4 M | $304M |
| 2022 Q4 | 131 | 69.4 M | $584M |
| 2022 Q3 | 106 | 65.3 M | $396M |
| 2022 Q2 | 106 | 35.1 M | $110M |
| 2022 Q1 | 137 | 37.4 M | $221M |
| 2021 Q4 | 149 | 33.5 M | $335M |
| 2021 Q3 | 167 | 44.7 M | $4.73B |
| 2021 Q2 | 170 | 44.8 M | $3.83B |
| 2021 Q1 | 168 | 44.2 M | $5.06B |
| 2020 Q4 | 160 | 42.9 M | $6.01B |
| 2020 Q3 | 132 | 34.6 M | $2.82B |
| 2020 Q2 | 127 | 35.3 M | $2.53B |
| 2020 Q1 | 118 | 34.0 M | $1.52B |
| 2019 Q4 | 130 | 32.2 M | $3.07B |
| 2019 Q3 | 112 | 33.5 M | $2.63B |
| 2019 Q2 | 76 | 25.2 M | $1.09B |
| 2019 Q1 | 73 | 22.9 M | $927M |
| 2018 Q4 | 66 | 17.4 M | $898M |
| 2018 Q3 | 68 | 16.1 M | $710M |